Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,826,199 | 1,155,721 | 586,576 | 1,970,335 | 1,412,741 |
| Depreciation Amortization | 148,834 | 91,783 | 39,148 | 155,610 | 115,217 |
| Income taxes - deferred | 11,339 | 20,409 | 11,305 | -24,969 | 18,498 |
| Accounts receivable | -290,013 | -217,911 | -89,073 | -257,161 | -259,086 |
| Accounts payable and accrued liabilities | 135,212 | 43,691 | -20,999 | 312,568 | 341,462 |
| Other Working Capital | -53,444 | -140,017 | -79,021 | -128,130 | -119,481 |
| Other Operating Activity | 346,651 | 310,571 | 193,394 | 115,131 | 55,746 |
| Operating Cash Flow | $2,124,778 | $1,264,247 | $641,330 | $2,143,384 | $1,565,097 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -367,330 | 41,194 | -164,318 | -52,963 | -333,198 |
| PPE Investments | -1,450,886 | -184,945 | -164,071 | -115,005 | -73,345 |
| Net Acquisitions | N/A | -1,247,816 | N/A | -10,851 | -10,851 |
| Investing Cash Flow | $-1,818,216 | $-1,391,567 | $-328,389 | $-178,819 | $-417,394 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400,000 | 400,000 | N/A | N/A | N/A |
| Debt Repayment | -511,013 | -305,463 | -36 | -4,326 | -3,749 |
| Common Stock Issued | 160,924 | 102,093 | 40,947 | 246,125 | 176,416 |
| Common Stock Repurchased | -756,491 | -468,244 | -230,065 | -1,969,582 | -1,216,068 |
| Other Financing Activity | -20,779 | -30,420 | 43,413 | 253,214 | 149,255 |
| Financing Cash Flow | $-727,359 | $-302,034 | $-145,741 | $-1,474,569 | $-894,146 |
| Exchange Rate Effect | -13,906 | 10,926 | 37,144 | 1,220 | -12,219 |
| Beginning Cash Position | 1,459,302 | 1,459,302 | 1,459,302 | 968,086 | 968,086 |
| End Cash Position | 1,024,599 | 1,040,874 | 1,663,646 | 1,459,302 | 1,209,424 |
| Net Cash Flow | $-434,703 | $-418,428 | $204,344 | $491,216 | $241,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,124,778 | 1,264,247 | 641,330 | 2,143,384 | 1,565,097 |
| Capital Expenditure | -1,450,886 | -184,945 | -164,071 | -115,005 | -73,345 |
| Free Cash Flow | 673,892 | 1,079,302 | 477,259 | 2,028,379 | 1,491,752 |